Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Allopurinol × Clear all

Phase

Status

Completed 4 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1

Interventions

Dexamethasone 54 Cyclophosphamide 35 Bortezomib 29 Melphalan 22 Lenalidomide 18 pomalidomide 14 Thalidomide 14 fludarabine 10 daratumumab 9 carfilzomib 7 Filgrastim 7 Doxorubicin 6 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Bendamustine Hydrochloride 5 ixazomib 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Clarithromycin 4 Calcium Dobesilate 4 selinexor 3 sargramostim 3 liposomal doxorubicin 3 isatuximab 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3 Interferon-alpha 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570983 2022-06-22

BEAM

Swedish Medical Center

Phase 2 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡